Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03032692
Other study ID # RCT-BFK01
Secondary ID
Status Completed
Phase N/A
First received January 24, 2017
Last updated June 12, 2017
Start date June 1, 2016
Est. completion date August 31, 2016

Study information

Verified date June 2017
Source Sword Health, SA
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study was designed to evaluate the impact of a novel kinematic biofeedback system - SWORD - in the motor performance of patients after stroke. The SWORD system combines inertial motion trackers and a mobile app, allowing digitization of patient motion and providing real-time audiovisual biofeedback.

The investigators hypothesize that the biofeedback feedback provided by the SWORD system improves patient performance, defined as an increase in the number of correct movements.

The design of the study is a cross-over randomized clinical trial. Patients will be randomized into two groups. Both will perform two separate sessions consisting of one exercise - shoulder flexion with elbow flexion at 90 degrees - for 4 minutes in both experimental settings: with and without biofeedback. Group 1 will perform the exercise with biofeedback first and without biofeedback after, with an interval >24h. Group 2 will perform the exercise in the opposite order. The SWORD system will be used to record movement data in both sessions, but the feedback was only active in one of them.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date August 31, 2016
Est. primary completion date August 31, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- clinical symptoms and signs and CT or MRI findings compatible with a lesion in the territory of the medial cerebral artery;

- persistent motor deficit on the upper limb but not plegia with a score between 0 and 2 on item 5b of the National Institute of Health Stroke Scale (NIHSS)

- more than 2 weeks after stroke onset;

- the ability to sit comfortably for more than 10 minutes and perform two-step commands

Exclusion Criteria:

- no detectable motor deficits at baseline assessment;

- severe aphasia;

- clinical dementia or mini mental state examination (MMSE) below cutoff;

- other cognitive or psychiatric comorbidity that impaired communication or compliance with the tasks;

- severe respiratory or cardiac condition incompatible with more than 5 minutes of continuous mild exercise in a sitting position;

- pain or deformity that limited upper limb movement on the affected side.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
SWORD
Both arms will perform two separate sessions consisting of one exercise - shoulder flexion with elbow flexion at 90 degrees - for 4 minutes in two experimental conditions: with and without biofeedback. Group 1 will perform the exercise with biofeedback first and without biofeedback after; group 2 performed the exercise in the opposite order. The SWORD system will be used to record movement data in both sessions.
Other:
Exercise with biofeedback

exercise without biofeedback


Locations

Country Name City State
Portugal CMM - Centro Médico de Aveiro Aveiro
Portugal CMM - Murtosa Murtosa Aveiro
Portugal CMM- Centro Médico de Viseu Viseu

Sponsors (4)

Lead Sponsor Collaborator
Sword Health, SA Centro Médico de Viseu, CMM - Centro Médico da Murtosa, CMM - Centro Médico de Aveiro

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of correct movements Number of correct movements performed within the duration of each exercise session At the end of each exercise session (4 minute duration)
Secondary Total number of repetitions Total number of repetitions performed within the duration of each exercise session At the end of each exercise session (4 minute duration)
Secondary Number of incorrect repetitions Number of incorrect repetitions performed within the duration of each exercise session At the end of each exercise session (4 minute duration)
Secondary Number of consecutive incorrect repetitions Number of consecutive incorrect repetitions performed within the duration of each exercise session At the end of each exercise session (4 minute duration)
Secondary Number of pauses Number of pauses registered during each exercise session At the end of each exercise session (4 minute duration)
Secondary Posture errors Number of posture errors registered during each exercise session At the end of each exercise session (4 minute duration)
Secondary Movement frequency Movement frequency (in Hertz) during each exercise session At the end of each exercise session (4 minute duration)
Secondary Range of motion of correct movements Mean range of motion of the correct movements performed during each exercise session At the end of each exercise session (4 minute duration)
Secondary Range of motion variability over time Variability of the mean range of motion during the exercise session (for correct movements) Between the second and first minute; between the second and third minutes; between the third and fourth minute
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05518305 - Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT03728738 - Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke Phase 3
Terminated NCT03396419 - IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
Recruiting NCT05065216 - Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) Phase 2/Phase 3
Recruiting NCT04897334 - Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke N/A
Not yet recruiting NCT06462599 - Osteopontin Gene Polymorphism in Stroke Patients in Egypt
Not yet recruiting NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Not yet recruiting NCT06032819 - Differentiating Between Brain Hemorrhage and Contrast
Recruiting NCT02910180 - Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Completed NCT02922452 - A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects Phase 1
Completed NCT03554642 - Walkbot Robotic Training for Improvement in Gait Phase 3
Withdrawn NCT01866189 - Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke N/A
Recruiting NCT03041753 - Reperfusion Injury After Stroke Study N/A
Completed NCT02549846 - AdminiStration of Statin On Acute Ischemic stRoke patienT Trial Phase 4
Completed NCT02610803 - Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke N/A
Completed NCT01678534 - Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial Phase 2